BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35582098)

  • 1. Vasoactive intestinal peptide secreting tumour: An overview.
    Una Cidon E
    World J Gastrointest Oncol; 2022 Apr; 14(4):808-819. PubMed ID: 35582098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological data and treatment modalities for pancreatic vipomas: a systematic review.
    Schizas D; Mastoraki A; Bagias G; Patras R; Moris D; Lazaridis II; Arkadopoulos N; Felekouras E
    J BUON; 2019; 24(2):415-423. PubMed ID: 31127985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of vasoactive intestinal peptide-secreting tumor (VIPoma) arising from MEN1 inactivation which recurred 15 years after the initial resection.
    Sakurai M; Wakabayashi T; Kondo Y; Ikeda E; Watanabe K; Takei A; Okazaki H; Okada K; Ebihara K; Kakiuchi N; Ogawa S; Fukushima N; Ishibashi S
    Endocr J; 2023 Jun; 70(6):573-579. PubMed ID: 36889692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative Hypotensive Crisis in an Adolescent with a Pancreatic VIPoma and MEN1-Gene Variant.
    Acosta-Gualandri A; Kao KT; Wong T; Webber E; Armstrong L; Panagiotopoulos C
    Horm Res Paediatr; 2019; 91(4):285-289. PubMed ID: 30326482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic VIPomas: subject review and one institutional experience.
    Ghaferi AA; Chojnacki KA; Long WD; Cameron JL; Yeo CJ
    J Gastrointest Surg; 2008 Feb; 12(2):382-93. PubMed ID: 17510774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vipomas].
    Dupont C
    Ann Med Interne (Paris); 1984; 135(5):400-2. PubMed ID: 6091517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor.
    Belei O; Basaca DG; Heredea ER; Iacob ER; Olariu L; Folescu R; Motoc AGM; Nanu AM; Mărginean O
    Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verner-Morrison syndrome. Literature review.
    Belei OA; Heredea ER; Boeriu E; Marcovici TM; Cerbu S; Mărginean O; Iacob ER; Iacob D; Motoc AGM; Boia ES
    Rom J Morphol Embryol; 2017; 58(2):371-376. PubMed ID: 28730220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic VIPomas from China: Case reports and literature review.
    Chen C; Zheng Z; Li B; Zhou L; Pang J; Wu W; Zheng C; Zhao Y
    Pancreatology; 2019 Jan; 19(1):44-49. PubMed ID: 30391116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Report: Irreversible Watery Diarrhea, Severe Metabolic Acidosis, Hypokalemia and Achloridria Syndrome Related to Vasoactive Intestinal Peptide Secreting Malignant Pheochromocytoma.
    Negro A; Verzicco I; Tedeschi S; Campanini N; Zanelli M; Negri E; Farnetti E; Nicoli D; Palladini B; Santi R; Cunzi D; Calvi A; Coghi P; Gerra L; Volpi R; Graiani G; Cabassi A
    Front Endocrinol (Lausanne); 2021; 12():652045. PubMed ID: 33815297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic mixed VIPoma/PPoma-induced diarrhoea causing renal failure.
    Brown G; Monaghan AM; Fristedt R; Ramsey E; Al-Mrayat M; Rajak R; Armstrong T; Takhar A
    Endocrinol Diabetes Metab Case Rep; 2022 Aug; 2022():. PubMed ID: 36001009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of symptoms and reduction of VIP levels after hepatic artery chemoembolization in a patient with sandostatin resistant VIPoma.
    Shaib W; Mitchell K; Saif MW
    Yale J Biol Med; 2010 Mar; 83(1):27-33. PubMed ID: 20351979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Management Challenges in Vasoactive Intestinal Peptide Secreting Tumors: A Series of 15 Patients.
    Angelousi A; Koffas A; Grozinsky-Glasberg S; Gertner J; Kassi E; Alexandraki K; Caplin ME; Kaltsas G; Toumpanakis C
    Pancreas; 2019 Aug; 48(7):934-942. PubMed ID: 31268974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VIPomas and the watery diarrhoea syndrome.
    Modlin IM; Bloom SR
    S Afr Med J; 1978 Jul; 54(2):53-6. PubMed ID: 705537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal polypeptide-secreting tumours: biology and therapy.
    Park SK; O'Dorisio MS; O'Dorisio TM
    Baillieres Clin Gastroenterol; 1996 Dec; 10(4):673-96. PubMed ID: 9113317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent primary hepatic VIPoma treated with a combination of surgical resection and loco-regional therapy.
    Dahmani W; Nasr S; Maalel K; Becheikh Y; Tibaoui A; Lajmi Z; Hmissa S; Jaziri H; Elleuch N; Slama AB; Ameur WB; Ksiaa M; Jmaa A
    Future Sci OA; 2023 Jan; 9(1):FSO836. PubMed ID: 37006228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VIPomas: an update in diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Safioleas M; Mallas E; Polyzos A
    Hepatogastroenterology; 2005; 52(64):1259-65. PubMed ID: 16001675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male.
    Abu-Zaid A; Azzam A; Abudan Z; Algouhi A; Almana H; Amin T
    Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):109-15. PubMed ID: 24785507
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.